The only FDA-approved treatments (disulfiram, naltrexone, and acamprosate) have been modestly successful in treating AUD (e.g., naltrexone reduces relapse rates by 5%) (for a detailed review and meta-analysis 1,2 ), but still are severely under-prescribed
Journal of Clinical Endocrinology & Metabolism, 109 (7), 18141826
"We are committed to confronting the stigma linked with chronic diseases, like obesity, and expanding access to our authentic, prescription-only medicines." For more on weight management: Hims & Hers Super Bowl ad slams pricey pharma industryand fumbles FDA warnings on compounded GLP-1 drugs Exclusive: The COO of Hims & Hers was the third person to try its new weight-loss drugsand she's ready to share her story Online searches predicted the surge in prescriptions of weight-loss drugs like Wegovy and Zepbound, study says
What is the recommended starting dose of tirzepatide (ZepBound)?
[DOI] [PubMed] [Google Scholar] 33.Mzsik G., Szab I.L., Czimmer J
Financial pressure pushes people toward the lowest-cost option, even when they understand the risks
